Department of Nephrology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, P. R. China.
Department of Nephrology, Liupanshui Municipal People's Hospital, Liupanshui, Guizhou Province, 553001, P. R. China.
BMC Nephrol. 2024 Sep 27;25(1):322. doi: 10.1186/s12882-024-03756-y.
Different initial manifestations of peritoneal dialysis-associated peritonitis (PDAP) may depend on the type of pathogenic organism. We investigated the association between the clinical characteristics of PDAP and susceptibility to vancomycin and investigated the possibility of using vancomycin monotherapy alone as an initial treatment regimen for some PDAP patients to avoid unnecessary antibiotic exposure and secondary infection.
Patients with culture-positive PDAP were retrospectively analyzed and divided into two groups: peritonitis with only cloudy effluent (PDAP-cloudy) or with cloudy effluent, abdominal pain and/or fever (PDAP-multi). The bacterial culture of PD effluent and antibiotic sensitivity test results were compared between groups. Logistic regression was used to investigate factors predicting susceptibility to vancomycin.
Of 162 episodes of peritonitis which had a positive bacterial culture of PD fluid, 30 peritonitis were in the PDAP-cloudy group, and 132 peritonitis were in the PDAP-multi group. Thirty (100%) peritonitis in the PDAP-cloudy group had gram-positive bacterial infections, which was significantly greater than that in the PDAP-multi group (51.5%) (P < 0.001). Twenty-nine (96.7%) peritonitis in the PDAP-cloudy group were susceptible to vancomycin, compared to 67 (50.8%) in the PDAP-multi group (P < 0.001). The specificity of PDAP-cloudy for vancomycin-sensitive peritonitis was 98.48%. Only one patient (3.3%) in the PDAP-cloudy group experienced vancomycin-resistant peritonitis caused by Enterococcus gallinarum, which could neither be covered by vancomycin nor by the initial antibiotic regimen recommended by the current ISPD guidelines. The presence of only cloudy effluent was an independent predictor of susceptibility to vancomycin according to multivariate analysis (OR = 27.678, 95% CI 3.191-240.103, p = 0.003), in addition to PD effluent WBC counts (OR = 0.988, 95% CI 0.980-0.996, p = 0.004), diabetes mellitus (OR = 3.646, 95% CI 1.580-8.416, p = 0.002), first episode peritonitis (OR = 0.447, 95% CI 0.207-0.962, p = 0.039) and residual renal creatinine clearance (OR = 0.956, 95% CI 0.918-0.995, p = 0.027). Addition of these characteristics increased the AUC to 0.813 (95% CI 0.0.749-0.878, P < 0.001). The specificity of presenting with only cloudy effluent for vancomycin-sensitive peritonitis was 98.48%.
Cloudy dialysate, as the only symptom at PDAP onset, was an independent predictor of vancomycin-sensitive PDAP, which is an important new insight that may guide the choice of initial antibiotic treatment.
不同类型的腹膜透析相关性腹膜炎(PDAP)的初始表现可能取决于病原体的类型。我们研究了 PDAP 的临床特征与对万古霉素敏感性之间的关系,并研究了单独使用万古霉素作为某些 PDAP 患者初始治疗方案的可能性,以避免不必要的抗生素暴露和继发感染。
回顾性分析培养阳性 PDAP 患者,分为仅混浊渗出液组(PDAP-混浊)和混浊渗出液、腹痛和/或发热组(PDAP-复杂)。比较 PD 流出液的细菌培养和抗生素药敏试验结果。使用 logistic 回归分析预测对万古霉素敏感性的因素。
在 162 例 PD 液培养阳性的腹膜炎中,30 例为 PDAP-混浊,132 例为 PDAP-复杂。30 例(100%)PDAP-混浊组为革兰氏阳性菌感染,明显高于 PDAP-复杂组(51.5%)(P<0.001)。29 例(96.7%)PDAP-混浊组对万古霉素敏感,而 PDAP-复杂组为 67 例(50.8%)(P<0.001)。PDAP-混浊对万古霉素敏感的特异性为 98.48%。PDAP-混浊组仅 1 例(3.3%)患者发生万古霉素耐药性腹膜炎,由鹑鸡肠球菌引起,万古霉素和现行 ISPD 指南推荐的初始抗生素方案均无法覆盖。根据多变量分析,仅混浊渗出液是对万古霉素敏感的独立预测因素(OR=27.678,95%CI 3.191-240.103,p=0.003),此外还有 PD 流出液白细胞计数(OR=0.988,95%CI 0.980-0.996,p=0.004)、糖尿病(OR=3.646,95%CI 1.580-8.416,p=0.002)、首次腹膜炎(OR=0.447,95%CI 0.207-0.962,p=0.039)和残余肾肌酐清除率(OR=0.956,95%CI 0.918-0.995,p=0.027)。增加这些特征后,AUC 增加至 0.813(95%CI 0.0.749-0.878,P<0.001)。仅混浊渗出液是万古霉素敏感 PDAP 的独立预测因素,特异性为 98.48%。
PDAP 发病时仅混浊渗出液是万古霉素敏感 PDAP 的独立预测因素,这是一个重要的新发现,可能有助于指导初始抗生素治疗方案的选择。